Spinach Extract (Thylakoids/Appethyl): A Real GLP-1 Appetite Suppressant?

Of all the "natural Ozempic" ingredients, spinach extract is one of the few with an actual mechanism, an actual human trial signal, and an actual brand built on it — Appethyl, the thylakoid concentrate sold as a "satiety" or "appetite" ingredient. That puts it a clear step above the average craving gummy. But "better than the average craving gummy" is a low bar, and the honest story here is more nuanced than either the marketing ("clinically proven to cut cravings") or the cynicism ("it's just spinach") allows. This is an independent, evidence-first read — consumer-health journalism, not medical advice — of what thylakoids really do, where the human signal comes from, and the funding caveat you need to weigh before believing the headline.

The short version up front: thylakoid membranes from spinach leaves have a plausible, well-characterized mechanism — they slow fat digestion and raise your own satiety hormones (GLP-1 and CCK) — and a small body of randomized trials, led by a Lund University group, reported reduced cravings and modest weight loss. But most of those headline trials were funded by or tied to the company commercializing the extract, independent replication is thin and mixed, and an independent meta-analysis pegs the appetite effect as real but small. Plausible mechanism plus an industry-weighted signal does not equal "a GLP-1 drug in a green powder."

What thylakoids actually are

A thylakoid is the internal membrane system inside a chloroplast — the green, light-harvesting machinery of a plant cell. Spinach leaves are dense with them. The "spinach extract" sold for appetite control (the best-known brand is Appethyl) is a concentrated, processed thylakoid-membrane powder, not whole spinach and not a spinach-leaf supplement in the ordinary sense. The processing matters, because the membrane's physical structure is the active part — heat and shear can aggregate or degrade it and change how it behaves in the gut, which is one reason results don't always transfer cleanly from one preparation to another.

So when a label says "spinach extract clinically shown to reduce cravings," the relevant evidence is specifically the thylakoid-concentrate trials — not the general (and substantial) case for eating leafy greens.

The mechanism: slowing fat digestion, raising satiety hormones

This is the genuinely interesting part, and it's where thylakoids earn their place above the typical "appetite" blend. The mechanism is two-step and reasonably well worked out in the lab.

First, thylakoid membranes physically slow fat digestion. In a foundational biochemistry study, chloroplast membranes retarded the activity of pancreatic lipase/co-lipase — the enzyme system that breaks down dietary fat — and induced satiety as a result¹. Slower fat digestion means fat lingers further down the small intestine.

Second, that delayed fat then triggers the gut's own satiety hormones. When undigested fat reaches the lower small intestine, it stimulates the L-cells and I-cells there to release GLP-1 and cholecystokinin (CCK) — the same satiety signals a "natural GLP-1" diet leans on. In healthy humans, thylakoids promoted the release of CCK while reducing insulin², and adding thylakoids to a high-carbohydrate meal decreased hunger and elevated CCK with a blunted post-meal response³. A 12-week human supplementation study from the Lund group reported increased GLP-1 release alongside its weight and craving outcomes⁴. Mechanistically, thylakoids also slowed gastric emptying and gut transit and shifted the gut microbial flora in a controlled human study⁵.

That is a real, coherent satiety mechanism — slowed fat digestion → more distal fat → more of your own GLP-1 and CCK → feeling full sooner and craving less. It's the same family of mechanism we describe for foods that genuinely raise your own GLP-1, just packaged as an extract. The honest caveat is the same one that applies to every endogenous-satiety lever: nudging your own GLP-1 up for a meal is a fundamentally different thing from a drug that floods the GLP-1 receptor continuously.

The Lund signal: what the human trials reported

The human evidence for body-weight and craving outcomes comes largely from one research environment — a group at Lund University in Sweden — and it is genuinely the most encouraging data in the "natural appetite suppressant" space.

The headline trial gave overweight women a daily thylakoid extract for 12 weeks and reported greater body-weight loss, a reduced urge for palatable ("hedonic") food, and increased GLP-1 release versus control⁴. A separate single-meal randomized study in overweight women found that thylakoid-rich spinach extract reduced hunger, increased satiety, and reduced cravings for palatable food across the day⁶. An independent US group (Rebello and colleagues at Pennington) ran an acute randomized crossover trial of a spinach thylakoid extract and likewise found a satiety effect after a single dose⁷, and the same group has discussed thylakoids within the broader science of curbing reward-driven, "hedonic" eating⁸.

Taken at face value, that's a believable, mechanism-consistent story: slow the fat, raise the satiety hormones, eat less of the food you crave most, lose a modest amount of weight over a few months. If you've read our scorecard of natural appetite suppressants, thylakoids slot in as one of the more interesting 🟡 entries — better-mechanized than most, but resting on a small, single-environment trial base.

The funding caveat — and what independent review found

Here is where the honest framing has to tighten. The most favorable thylakoid trials were conducted by, or in close collaboration with, the academic group that developed the extract and has a commercial interest in it. Industry-tied nutrition trials are not automatically wrong, but the literature is clear that sponsor-linked studies skew toward favorable results — so a body of evidence dominated by the originating group is a weaker foundation than the same number of trials run by unrelated labs. Independent replication of the weight-loss and craving outcomes is, so far, thin.

When the evidence is pooled by independent reviewers, the effect shrinks to "real but small." A 2025 systematic review and dose-response meta-analysis of randomized controlled trials concluded that combining thylakoids with meals was associated with reduced hunger and increased fullness — but the effect sizes were modest (a few millimeters on a 100-mm visual-analog appetite scale), and the authors explicitly noted that the existing trials are inconsistent⁹. An earlier systematic review of thylakoid intake for appetite and weight loss reached a similarly cautious verdict: a plausible signal, but a small and not-yet-robust evidence base¹⁰. Much of the supporting mechanistic work, meanwhile, is in mice, pigs, and rats — animal models reduced body fat and modulated appetite hormones¹¹¹² — which is encouraging for plausibility but cannot stand in for durable human outcome data.

So the fair summary is: the mechanism is strong, the acute satiety-hormone data in humans are reasonably solid, but the marquee "lose weight and crush cravings" outcomes lean heavily on industry-linked trials and have not been convincingly replicated by independent groups at scale.

The honest yardstick: this is not Ozempic

Because thylakoid products are explicitly marketed in the GLP-1 conversation, the comparison has to be made plainly. Semaglutide (Ozempic, Wegovy) is an engineered peptide that binds and activates the GLP-1 receptor directly, at pharmacologic levels, continuously — and in the STEP-1 trial it produced roughly 15% mean body-weight loss over 68 weeks¹³. Thylakoids, at their best, prompt your gut to release a bit more of your own GLP-1 and CCK around a meal, for a modest reduction in hunger and a small weight effect over months.

Those are different orders of magnitude. We lay out the full size of that gap in supplements vs GLP-1 drugs; the one-line version is that no endogenous-satiety lever, thylakoids included, comes close to what receptor-level drug activation does. A thylakoid extract is best understood as a possible margin-improver on top of a protein-and-fiber diet — not a substitute for a medication.

Is it worth taking?

If you want to try thylakoid spinach extract, the case for it is "low risk, plausible mechanism, modest and uncertain benefit." A few honest pointers:

1. 1.Match the trial conditions. The human signal is for a meaningful daily dose of an actual thylakoid concentrate (Appethyl-type), taken with meals — not a pinch of generic "spinach extract" buried in a proprietary blend. Under-dosed or degraded preparations have no reason to reproduce the trial results.
2. 2.Expect a craving/satiety nudge, not weight-loss magic. The most replicated effect is reduced hunger and reduced urge for palatable food within a day; the durable weight outcomes are smaller and rest on weaker, industry-tied data.
3. 3.It pairs logically with the proven levers. Its fat-delay-to-satiety mechanism complements — it doesn't replace — leading meals with protein and adding viscous fiber, the two best-evidenced natural satiety tools.
4. 4.Discount the marketing math. "Clinically proven" here means a handful of small trials, several from the group selling it. Treat the brand claims as the ceiling, not the expectation.

For the broader category — including the craving-specific ingredients people reach for alongside it — see our reads on supplements to stop sugar cravings and whether saffron extract curbs snacking.

The honest bottom line

Spinach thylakoid extract (Appethyl) is one of the more scientifically respectable "natural appetite suppressants": it has a genuine, well-characterized mechanism — slowing fat digestion to raise your own GLP-1 and CCK — and acute human data showing it really does blunt hunger and cravings around a meal. But the headline weight-loss and craving results come largely from the Lund group that developed and commercializes the extract, independent replication is thin, and when independent reviewers pool the trials the appetite effect is real but small and the studies are inconsistent. It is a plausible, low-risk margin tool to stack on a protein-and-fiber diet — not the drug-like result the "natural Ozempic" framing implies.

For the full mechanism picture, start with our pillar on what 'natural GLP-1' supplements really show, and to see where every ingredient and product we've vetted lands on price and evidence, see our best natural GLP-1 supplements hub.